NeoGenomics (NASDAQ: NEO) reported Q3 EPS of ($0.14), $0.06 better than the analyst estimate of ($0.20). Revenue for the quarter came in at $128.78 million versus the consensus estimate of $122.41 million.

For earnings history and earnings-related data on NeoGenomics (NEO) click here.